Korean Drug Co., Ltd.
Research Korean Drug Co., Ltd. (014570.KQ) on Bullrun: market cap KRW 33.02B, dividend yield 5.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker014570.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyKRW
- Market capKRW 33.02B
- Dividend yield5.9%
- Financial periodQ2 2026
- RevenueKRW 17.57B
- Net income-KRW 3.44B
- Free cash flowKRW 1.89B
- Gross margin46.9%
Valuation Snapshot
latest market cap is KRW 33.02B; dividend yield is 5.9%.
Peer valuation comparison
Latest dividend yield is 5.9% versus a Healthcare sector median of 2.4% (145.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 33.02B | n/a | 5.9% | 180 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 180 KRW, yield 5.9%.
About Korean Drug Co., Ltd.
Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Korean Drug Co., Ltd.'s market cap?
Korean Drug Co., Ltd.'s market capitalization is KRW 33.02B.
Does Korean Drug Co., Ltd. pay a dividend?
Korean Drug Co., Ltd. has a dividend yield of 5.9%.
What does Korean Drug Co., Ltd. do?
Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.